-
1.
公开(公告)号:EP1603488A2
公开(公告)日:2005-12-14
申请号:EP04717435.4
申请日:2004-03-04
申请人: Synecor, LLC
发明人: STACK, Richard, S. , SILVERSTEIN, Fred, E. , EVERY, Nathan , ATHAS, William, L. , WILLIAMS, Michael, S. , GLENN, Richard, A. , LUNSFORD, John , BALBIERZ, Dan
IPC分类号: A61F2/04
CPC分类号: A61F5/0076 , A61F2/04 , A61F5/0079 , A61F5/0089 , A61F2002/044
摘要: A prosthetic device is described that is positionable within the gastro-esophageal junction region (6) of a patient. The prosthetic device includes a proximal opening (12) and a distal orifice (14) that is adjustable in size prior to and/or following implantation. During use, the prosthetic device is attached to tissue of the gastro-esophageal junction region of the patient, with the device positioned such that food ingested by the patient passes from the esophagus through the proximal opening into the interior of the prosthetic device, and eventually exits the prosthetic device via the distal opening.
-
公开(公告)号:EP1603488B1
公开(公告)日:2010-04-21
申请号:EP04717435.4
申请日:2004-03-04
申请人: Synecor, LLC
发明人: STACK, Richard, S. , SILVERSTEIN, Fred, E. , EVERY, Nathan , ATHAS, William, L. , WILLIAMS, Michael, S. , GLENN, Richard, A. , LUNSFORD, John , BALBIERZ, Dan
IPC分类号: A61F5/00
CPC分类号: A61F5/0076 , A61F2/04 , A61F5/0079 , A61F5/0089 , A61F2002/044
-
公开(公告)号:EP1420730A2
公开(公告)日:2004-05-26
申请号:EP02757395.5
申请日:2002-08-26
申请人: Synecor, LLC
发明人: STACK, Richard, S. , GLENN, Richard, A. , MOODY, Trevor, J. , SILVERSTEIN, Fred, E. , EVERY, Nathan , EUBANKS, William, S., Jr.
CPC分类号: A61F5/0076 , A61F2/04 , A61F2/07 , A61F2/24 , A61F5/0069 , A61F5/0079 , A61F2002/044 , A61F2002/045 , A61F2002/067 , A61F2002/072 , A61F2002/8483 , A61F2250/0039 , A61F2250/0067
摘要: A device for inducing weight loss in a patient includes a tubular prosthesis self-expandable from a collapsed position in which the prosthesis has a first diameter to an expanded position in which the prosthesis has a second, larger, diameter. In a method for inducing weight loss, the prosthesis is placed in the collapsed position and inserted into a stomach of a patient. The prosthesis is allowed to self-expand from the collapsed position to the expanded position and into contact with the walls of the stomach, where it induces feelings of satiety and/or inhibits modulation of satiety-controlling factors such as Ghrelin.
-
-